Size-tunable synthetic particles with tunable optical properties and methods for using the same for immune cell activation
Inventors
Zhang, Daixuan • STONEBLOOM, Solomon • ARMAS, Juan • KETHAR, Harini • Thomas, Sunil • DE GEUS, Martina
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
A hydrogel particle, comprising a matrix comprising a polymerized monomer, said matrix comprising a plurality of micropores and a plurality of macropores, and one or more immunostimulatory biomolecules selected from the group consisting of an anti-CD3 antibody or antigen-binding fragment thereof, an anti-CD28 antibody or antigen-binding fragment thereof, and combinations thereof.
Core Innovation
The disclosure features porous hydrogel particles comprising a polymerized monomer matrix with micropores and macropores, along with immunostimulatory or co-stimulatory biomolecules. The micropores form during monomer polymerization, whereas macropores form through porogen removal. Upon contacting an immune cell, the particles induce an immune-cell response comprising activation or expansion, providing configurations defining macropore diameters between about 200 nm and about 2 µm and particle diameters between about 1 µm and about 25 µm.
The particles present biomolecules attached to or embedded within the matrix for cell support and immune-cell activation, yielding readouts such as increased CD69 and CD25 signals and IL-2 secretion. In addition, the particles function as tunable optical calibrants that mimic target-cell forward scatter, side scatter, and fluorescence. Increasing porogen concentration increases particle porosity and side scatter with little change in forward scatter, while nanoparticles provide additional independent side-scatter tuning.
Claims Coverage
The independent claims cover four inventive features directed to porous, biomolecule-presenting particles for inducing immune-cell activation and/or expansion.
Macropore diameter between about 200 nm and about 2 µm
Claim 1 covers a particle comprising a polymerized monomer matrix with micropores and macropores having an average diameter between about 200 nm and about 2 µm, and one or more immunostimulatory or co-stimulatory biomolecules, wherein the particle is capable of inducing immune-cell activation and/or expansion upon contact with an immune cell.
Higher immune-cell response relative to particles lacking macropores
Claim 22 covers a particle comprising a polymerized monomer matrix with micropores and macropores and one or more immunostimulatory or co-stimulatory biomolecules, wherein the particle induces an immune-cell response comprising activation and/or expansion that is higher than the response of a control immune cell contacted with an otherwise identical particle lacking the macropores.
Micropores formed during monomer polymerization
Claim 42 covers a particle comprising a polymerized monomer matrix with micropores and macropores and one or more immunostimulatory or co-stimulatory biomolecules, wherein the micropores are formed during monomer polymerization, and the particle induces immune-cell activation and/or expansion upon contact.
Particle diameter between about 1 µm and about 25 µm
Claim 61 covers a particle having a diameter between about 1 µm and about 25 µm, comprising a polymerized monomer matrix with micropores and macropores and one or more immunostimulatory or co-stimulatory biomolecules, capable of inducing immune-cell activation and/or expansion.
The independent claims collectively cover a porous polymerized-monomer matrix with immune-response-inducing biomolecules, individually defining macropore dimensions, an enhanced immune response relative to particles lacking macropores, micropore formation during polymerization, and a specified particle diameter range.
Stated Advantages
The increased surface area supports greater biomolecule loading, while the pores support nutrient transport and cell contact.
The particle is capable of inducing an immune-cell response comprising activation and/or expansion upon contact with an immune cell.
The immune-cell response is higher with the macroporous particle than with an otherwise identical particle lacking macropores.
Porous particles bearing immunostimulatory biomolecules show increased Jurkat-cell activation compared with Dynabeads, with CD69 and CD25 activation described as sustained.
Increasing porosity increases side scatter with little change in forward scatter, and nanoparticles provide additional, independent side-scatter tuning.
Documented Applications
Flow-cytometry controls and tunable optical calibrants that mimic target-cell forward scatter, side scatter, and fluorescence for cell-surface-marker detection and cytometric calibration.
Cell culture and expansion, including support or activation of immune cells such as chimeric antigen receptor (CAR) T cells.
Adoptive cell therapy.
Inducing immune-cell activation and/or expansion, documented by activation readouts including CD69, CD25, and IL-2 signals.
Interested in licensing this patent?